Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:00 PM
Ignite Modification Date:
2025-12-24 @ 1:00 PM
NCT ID:
NCT05405361
Eligibility Criteria:
Inclusion Criteria:
* Capable of providing signed informed consent and complying with protocol requirements. Participants must be able to read and write.
* Must have completed the double-blinded treatment period of the ARGX-117-2002 trial and considered to be eligible for treatment with ARGX-117.
Exclusion Criteria:
* Clinically significant uncontrolled active or chronic bacterial, viral, or fungal infection.
* Clinical evidence of other significant serious diseases, have had a recent major surgery, or who have any other condition, in the opinion of the investigator, that could confound the results of the trial or put the participant at undue risk.
* Currently participating in another interventional clinical study.
* Pregnant or lactating or intend to become pregnant during the trial or within 15 months after last dose of the study drug.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05405361
Study Brief:
Protocol Section:
NCT05405361